Pazopanib Shows Activity in EWSR1-NFATC2 Bone Sarcoma
https://reachmd.com/news/pazopanib-shows-activity-in-ewsr1-nfatc2-bone-sarcoma/2456858/
"Pazopanib is a multi-kinase inhibitor that is currently approved for treatment of advanced renal cell carcinoma and chemotherapy-refractory soft tissue sarcoma."BUFFALO, NY- January 12, 2024 – A new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, "Activity of…
Mount Sinai Experts to Present New Research on Long COVID, Lung Cancer, Asthma, Sleep Apnea, and More at ATS 2024 International Conference
https://reachmd.com/news/mount-sinai-experts-to-present-new-research-on-long-covid-lung-cancer-asthma-sleep-apnea-and-more-at-ats-2024-international-conference/2463148/
Mount Sinai Experts to Present New Research on Long COVID, Lung Cancer, Asthma, Sleep Apnea, and more at ATS 2024 International ConferenceAvailable for interview on breaking news, trending topics in respiratory medicineNewswise — World renowned pulm…
Gut Bacteria Can Process Dietary Fiber into an Anti-Allergy Weapon, Finds New Study
https://reachmd.com/news/gut-bacteria-can-process-dietary-fiber-into-an-anti-allergy-weapon-finds-new-study/2457023/
image: Gu…
New Method to Fight Age-Related Vision Loss Unveiled
https://reachmd.com/news/new-method-to-fight-age-related-vision-loss-unveiled/2466970/
Cirrus Therapeutics , the University of Bristol, and London's Global University Institute of Ophthalmology have discovered a revolutionary treatment for age-related macular degeneration (AMD), the leading cause of vision loss among older adults.Featured on the cover of the journal Science Translat…
Candel Wins FDA Orphan Drug Designation for Pancreatic Cancer Drug
https://reachmd.com/news/candel-wins-fda-orphan-drug-designation-for-pancreatic-cancer-drug/2463134/
Though a range of therapies are available for pancreatic cancer, survival rate remains low. Image credit…
Possible Alzheimer's Disease Without Symptoms: New Study
https://reachmd.com/news/possible-alzheimers-disease-without-symptoms-new-study/2463056/
Everyone experiences aging in their own way, and factors such as genetics, lifestyle and environment play a role in this process. Some individuals reach the age of 90 or even 100 in good health, without medications or brain disease. But how do these individuals maintain their health as they age? …
A Third COVID Vaccine Dose Improves Defense for Some Clinically Extremely Vulnerable Patients
https://reachmd.com/news/a-third-covid-vaccine-dose-improves-defense-for-some-clinically-extremely-vulnerable-patients/2463000/
Credit: Towfiqu barbhuiya from Pexels A major clinical trial has found that an additional COVID-19 vaccine dose led to the majority of clinically extremely vulnerable people mounting defensive antibod…
Artificial Sweetener Has Potential to Damage Gut, Finds Study
https://reachmd.com/news/artificial-sweetener-has-potential-to-damage-gut-finds-study/2462867/
Schematic to show the direct (T1R3-dependent) and indirect (bacteria-dependent) impact of the artificial sweetener neotame on the intestinal epithelial cell. Credit: Frontiers in Nutrition (2024). DOI: 10.3389/fnut.2024.136640…
Study Finds Potential New Treatment Path for Lasting Lyme Disease Symptoms
https://reachmd.com/news/study-finds-potential-new-treatment-path-for-lasting-lyme-disease-symptoms/2462797/
Expression levels of FGFRs from rhesus frontal cortex (FC) in response to live and non-viable B burgdorferi. FC tissue explants exposed to either live or sonicated B burgdorferi for 4 hrs. were probed for FGFR1-3 expression le…
New Heated Drug Baths Provide Hope for Patients with Stomach Cancer
https://reachmd.com/news/new-heated-drug-baths-provide-hope-for-patients-with-stomach-cancer/2462735/
Cancer New heated drug baths provide hope for patients with stomach cancer April 4, 2024 Mayo Clinic researchers used a new approach to chemotherapy to more than double the typical survival rate for patients with stomach cancer and peritoneal metastasis, w…